AUD 0.02
(0.0%)
Year | Inventory | Inventory Growth |
---|---|---|
2024 | 491.25 Thousand NZD | -12.81% |
2023 | 563.44 Thousand NZD | 13.39% |
2022 | 496.88 Thousand NZD | -32.17% |
2021 | 732.57 Thousand NZD | 45.42% |
2020 | 503.76 Thousand NZD | -35.58% |
2019 | 782.02 Thousand NZD | 76.04% |
2018 | 444.23 Thousand NZD | -4.98% |
2017 | 467.52 Thousand NZD | 698.07% |
2016 | 58.58 Thousand NZD | -45.24% |
2015 | 106.98 Thousand NZD | -88.65% |
2014 | 942.42 Thousand NZD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 FY | 491.25 Thousand NZD | -12.81% |
2024 Q4 | 491.25 Thousand NZD | 0.0% |
2024 Q1 | 640.99 Thousand NZD | 13.76% |
2024 Q2 | 640.99 Thousand NZD | 0.0% |
2024 Q3 | 491.25 Thousand NZD | -23.36% |
2023 Q4 | 563.44 Thousand NZD | 0.0% |
2023 Q3 | 563.44 Thousand NZD | -20.33% |
2023 Q2 | 707.2 Thousand NZD | 0.0% |
2023 Q1 | 707.2 Thousand NZD | 42.33% |
2023 FY | 563.44 Thousand NZD | 13.39% |
2022 Q4 | 496.88 Thousand NZD | 0.0% |
2022 Q2 | 691.6 Thousand NZD | 0.0% |
2022 FY | 496.88 Thousand NZD | -32.17% |
2022 Q1 | 691.6 Thousand NZD | -5.59% |
2022 Q3 | 496.88 Thousand NZD | -28.15% |
2021 Q3 | 732.57 Thousand NZD | 19.94% |
2021 Q4 | 732.57 Thousand NZD | 0.0% |
2021 FY | 732.57 Thousand NZD | 45.42% |
2021 Q1 | 610.77 Thousand NZD | 21.24% |
2021 Q2 | 610.77 Thousand NZD | 0.0% |
2020 Q4 | 503.76 Thousand NZD | 0.0% |
2020 FY | 503.76 Thousand NZD | -35.58% |
2020 Q3 | 503.76 Thousand NZD | -36.87% |
2020 Q2 | 797.98 Thousand NZD | 0.0% |
2020 Q1 | 797.98 Thousand NZD | 2.04% |
2019 FY | 782.02 Thousand NZD | 76.04% |
2019 Q4 | 782.02 Thousand NZD | 0.0% |
2019 Q3 | 782.02 Thousand NZD | 12.02% |
2019 Q1 | 698.13 Thousand NZD | 74.02% |
2019 Q2 | 698.13 Thousand NZD | 0.0% |
2018 Q1 | 756.11 Thousand NZD | 61.73% |
2018 FY | 444.23 Thousand NZD | -4.98% |
2018 Q4 | 401.18 Thousand NZD | 0.0% |
2018 Q3 | 401.18 Thousand NZD | -46.94% |
2018 Q2 | 756.11 Thousand NZD | 0.0% |
2017 Q1 | 267.7 Thousand NZD | 356.97% |
2017 Q4 | 467.52 Thousand NZD | 0.0% |
2017 FY | 467.52 Thousand NZD | 698.07% |
2017 Q2 | 267.7 Thousand NZD | 0.0% |
2017 Q3 | 467.52 Thousand NZD | 74.64% |
2016 Q2 | 80.36 Thousand NZD | 0.0% |
2016 FY | 58.58 Thousand NZD | -45.24% |
2016 Q4 | 58.58 Thousand NZD | 0.0% |
2016 Q3 | 58.58 Thousand NZD | -27.11% |
2016 Q1 | 80.36 Thousand NZD | -24.88% |
2015 Q3 | 106.98 Thousand NZD | -87.75% |
2015 Q1 | 873.56 Thousand NZD | 0.0% |
2015 FY | 106.98 Thousand NZD | -88.65% |
2015 Q2 | 873.56 Thousand NZD | 0.0% |
2015 Q4 | 106.98 Thousand NZD | 0.0% |
2014 FY | 942.42 Thousand NZD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
4DMedical Limited | 992.24 Thousand AUD | 50.491% |
Adherium Limited | 1.58 Million AUD | 68.953% |
Aroa Biosurgery Limited | 7.43 Million AUD | 93.388% |
Atomo Diagnostics Limited | 1.83 Million AUD | 73.283% |
Anteris Technologies Ltd | 646.71 Thousand AUD | 24.038% |
Control Bionics Limited | 404.15 Thousand AUD | -21.552% |
CardieX Limited | 2.55 Million AUD | 80.762% |
Compumedics Limited | 13.21 Million AUD | 96.281% |
Cochlear Limited | 391.6 Million AUD | 99.875% |
CleanSpace Holdings Limited | 2.86 Million AUD | 82.856% |
Cyclopharm Limited | 10.12 Million AUD | 95.147% |
EMVision Medical Devices Ltd | - AUD | -Infinity% |
Nova Eye Medical Limited | 4.28 Million AUD | 88.53% |
HeraMED Limited | 361.61 Thousand AUD | -35.851% |
Imricor Medical Systems, Inc. | 2.46 Million AUD | 80.063% |
ImpediMed Limited | 759 Thousand AUD | 35.276% |
InhaleRx Limited | - AUD | -Infinity% |
LBT Innovations Limited | 1.61 Million AUD | 69.638% |
Micro-X Limited | 5.37 Million AUD | 90.867% |
Neurotech International Limited | - AUD | -Infinity% |
OncoSil Medical Limited | 391.67 Thousand AUD | -25.425% |
PolyNovo Limited | 8.97 Million AUD | 94.525% |
Respiri Limited | 2.75 Million AUD | 82.146% |
SomnoMed Limited | 6.28 Million AUD | 92.184% |
Universal Biosensors, Inc. | 4.37 Million AUD | 88.779% |
Uscom Limited | 623.62 Thousand AUD | 21.226% |
Visioneering Technologies, Inc. | 3.16 Million AUD | 84.488% |